--- title: "Rising Pharma Holding, Inc. Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search Rising Pharma Holding, Inc. recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/rising-pharma-holding-inc/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # Rising Pharma Holding, Inc. recall records **13** reported ongoing 13 records in this archive. Latest source date Jul 13, 2026. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Jul 13, 2026 FDA drug enforcement ### [Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Labor...](https://isitonrecall.com/recall/fda-drug-d-0724-2026-rising-cyproheptadine-hydrochloride-syrup-2mg-5-ml-473-ml-one-pint-rx-only-manufactured-for-rising-p/) Presence of Precipitate: medication was crystallizing and particles floating in the bottle Class II Reported ongoing Distribution: Nationwide U.S.A. [Official source for Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured fo...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0724-2026%22) Mar 3, 2026 FDA drug enforcement ### [Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan...](https://isitonrecall.com/recall/fda-drug-d-0384-2026-product-label-temozolomide-capsules-5mg-packaged-in-5-capsule-bottles-rx-only-manufactured-for-risin/) Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing Class II Reported ongoing Distribution: Nationwide within the U.S [Official source for Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured f...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0384-2026%22) Oct 7, 2025 FDA drug enforcement ### [Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured b...](https://isitonrecall.com/recall/fda-drug-d-0029-2026-carbidopa-levodopa-entacapone-tablets-25-mg-100-mg-200-mg-100-count-bottle-rx-only-manufactured-for/) Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 ... Class II Reported ongoing Distribution: Distributed Nationwide in the USA [Official source for Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufact...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0029-2026%22) Mar 5, 2025 FDA drug enforcement ### [Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99](https://isitonrecall.com/recall/fda-drug-d-0277-2025-duloxetine-delayed-release-capsules-usp-30-mg-1-000-count-bottle-rx-only-distributed-by-rising-healt/) CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit. Class II Reported ongoing Distribution: Nationwide in the USA. [Official source for Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Ris...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0277-2025%22) Dec 30, 2024 FDA drug enforcement ### [Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc.,...](https://isitonrecall.com/recall/fda-drug-d-0188-2025-duloxetine-delayed-release-capsules-usp-30-mg-a-30-count-ndc-57237-018-30-and-b-1000-count-ndc-57237/) CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit. Class II Reported ongoing Distribution: Nationwide [Official source for Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0188-2025%22) Dec 30, 2024 FDA drug enforcement ### [Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ NDC 57237-017-60](https://isitonrecall.com/recall/fda-drug-d-0189-2025-duloxetine-delayed-release-capsules-usp-20-mg-60-count-bottles-rx-only-distributed-by-rising-pharm-h/) CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit. Class II Reported ongoing Distribution: Nationwide [Official source for Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Distributed by: Rising ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0189-2025%22) Dec 30, 2024 FDA drug enforcement ### [Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019-99) bottles; Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ](https://isitonrecall.com/recall/fda-drug-d-0190-2025-duloxetine-dr-capsules-usp-60-mg-a-30-count-ndc-57237-019-30-and-b-1000-count-ndc-57237-019-99-bottl/) CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit. Class II Reported ongoing Distribution: Nationwide [Official source for Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000 count (NDC 57237-019...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0190-2025%22) Nov 19, 2024 FDA drug enforcement ### [Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ NDC 57237-017-60](https://isitonrecall.com/recall/fda-drug-d-0105-2025-duloxetine-delayed-release-capsules-usp-20-mg-60-count-bottles-rx-only-distributed-by-rising-pharma/) CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit Class II Reported ongoing Distribution: Nationwide. [Official source for Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Distributed by: Rising...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0105-2025%22) Nov 19, 2024 FDA drug enforcement ### [Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC 57237-018-90) and c) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed...](https://isitonrecall.com/recall/fda-drug-d-0106-2025-duloxetine-delayed-release-capsules-usp-30-mg-a-30-count-ndc-57237-018-30-b-90-count-ndc-57237-018-9/) CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit Class II Reported ongoing Distribution: Nationwide. [Official source for Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30), b) 90 count (NDC ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0106-2025%22) Nov 19, 2024 FDA drug enforcement ### [Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 and c) 1000 count (NDC 57237-019-99) bottles, Distributed by: Rising Pharmaceutica...](https://isitonrecall.com/recall/fda-drug-d-0107-2025-duloxetine-dr-capsules-usp-60-mg-a-30-count-ndc-57237-019-30-b-90-count-ndc-57237-019-90-and-c-1000/) CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit Class II Reported ongoing Distribution: Nationwide. [Official source for Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count NDC 57237-019-90 an...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0107-2025%22) Jun 24, 2024 FDA drug enforcement ### [Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., Brockton, MA 02301; Mfd. For: Rising Pharmaceuticals, Inc., East Brunswick, NJ 0...](https://isitonrecall.com/recall/fda-drug-d-0599-2024-diflorasone-diacetate-ointment-usp-0-05-60g-tube-rx-only-mfd-by-lyne-laboratories-inc-brockton-ma-02/) Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit. Class III Reported ongoing Distribution: Nationwide in the USA [Official source for Diflorasone Diacetate Ointment, USP, 0.05%, 60g tube, Rx only, Mfd. By: Lyne Laboratories, Inc., ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0599-2024%22) May 16, 2024 FDA drug enforcement ### [Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-...](https://isitonrecall.com/recall/fda-drug-d-0541-2024-pregabalin-capsules-50mg-1000-count-bottle-rx-only-manufactured-for-rising-pharma-holdings-inc-east/) Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg. Class III Reported ongoing Distribution: Nationwide in the USA [Official source for Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, I...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0541-2024%22) Dec 29, 2023 FDA drug enforcement ### [buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured...](https://isitonrecall.com/recall/fda-drug-d-0222-2024-bupropion-hydrochloride-extended-release-tablets-usp-xl-150mg-30-count-bottles-rx-only-manufactured/) Presence of Foreign Tablets/Capsules Class II Reported ongoing Distribution: Nationwide within the United States [Official source for buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manu...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0222-2024%22) ## Reasons in these listed records - Presence of Precipitate: medication was crystallizing and particles floating in the bottle - Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing - Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg). - CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit. These examples come from this result page and are not a ranking of every recall reason. ## Checking Rising Pharma Holding, Inc. ### Is there a recall on rising pharma holding, inc. right now? This archive contains 13 records, including 13 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search Rising Pharma Holding, Inc.](https://isitonrecall.com/check/?q=Rising%20Pharma%20Holding%2C%20Inc.) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)